new approaches to decreasing preterm births with Makena (hydroxyprogesterone) and terbutaline
May 2011
Please see the November 2011 FDA statement concerning Makena.
One in eight babies is born prematurely in the United States.
Makena (mah-KEE-na) is the first drug APPROVED for reducing the risk of preterm birth...but it's not really new.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote